ask="1.95"
ask_size="1000"
average_daily_volume="50232"
bid="1.68"
bid_size="700"
book_value="0.81"
change="+0.05"
change_from_200_day_moving_average="0.11"
change_from_50_day_moving_average="0.30"
change_from_52_week_high="-1.82"
change_From_52_week_low="0.66"
change_in_percent="+2.73%"
close="1.88"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-6.98M"
eps_estimate_current_year="-0.16"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.48"
ex_dividend_date="N/A"
float_shares="2843000"
high="2.05"
high_52_weeks="3.70"
last_trade_date="2/6/2017"
last_trade_price="1.88"
last_trade_size="100"
last_trade_time="3:57pm"
low="1.82"
low_52_weeks="1.22"
market_capitalization="20.66M"
moving_average_200_day="1.77"
moving_average_50_day="1.58"
name="Cleveland BioLabs
Inc."
notes="N/A"
one_year_target_price="2.00"
open="1.82"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+6.33%"
percent_change_from_50_day_moving_average="+18.69%"
percent_change_from_52_week_high="-49.19%"
percent_change_from_52_week_low="+54.10%"
previous_close="1.83"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.26"
price_per_sales="5.29"
revenue="3.80M"
shares_outstanding="10987000"
short_ratio="0.08"
stock_exchange="NCM"
symbol="CBLI"
volume="146443"
weeks_range_52="1.22 - 3.70"
